| 标题 |
299MO DESTINY-Breast06 (DB-06) post-hoc analysis by physician’s choice of chemotherapy (TPC): Efficacy and safety of trastuzumab deruxtecan (T-DXd) vs TPC in hormone receptor–positive (HR+), HER2-low or -ultralow metastatic breast cancer (mBC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:C. Barrios; A. Bardia; X. Hu; R. Dent; K. Yonemori; et al 出版日期:2025-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)